[Elsevier] Immunoglobulin dynamics and infection risk with ofatumumab versus ocrelizumab in multiple sclerosis

Lauraz Post time 7 day(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-09-11 18:53
Reward10points

journal:Multiple Sclerosis and Related Disorders

Authors:Katarina Teija; Maan Sredanovi; Laura Zanetti; Tereza Gabeli; Ivan Adamec; Barbara Barun; Magdalena Krbot Skori; Mario Habek

Published date:2026-9-

DOI:10.1016/j.msard.2026.107373

PDF link:https://www.sciencedirect.com/sc ... 211034826004098/pdf

Article link:https://doi.org/10.1016/j.msard.2026.107373

Article Source:Elsevier BV


Remark:

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
dutzzi29 Post time 7 day(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    10

Return to the list